Affibody-derived drug conjugates targeting her2: effect of drug load on cytotoxicity and biodistribution

HIGHLIGHTS

• who: Haozhong Ding and colleagues from the Department of Protein Science, KTH Royal Institute of Technology, Roslagstullsbacken, Department of Immunology, Genetics and Pathology, University, Dag Hammarskjölds väg , have published the Article: Affibody-Derived Drug Conjugates Targeting HER2: Effect of Drug Load on Cytotoxicity and Biodistribution, in the Journal: Pharmaceutics 2021, 430 of 28/08/2015
• what: This study investigated the impact of drug loading on HER2-specific drug conjugates This study investigated the impact of drug loadingAffibody on HER2-specific drug conjugates based on an affibody scaffold protein (AffiDCs). molecules possess favorable based . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.